Advertisement
Advertisement

ELV

ELV logo

Elevance Health, Inc.

407.50
USD
Sponsored
-7.28
-1.76%
Sep 04, 15:59 UTC -4
Closed
exchange

After-Market

412.50

+5.00
+1.23%

ELV Earnings Reports

Positive Surprise Ratio

ELV beat 32 of 42 last estimates.

76%

Next Report

Date of Next Report
Oct 19, 2026
Estimate for Q3 26 (Revenue/ EPS)
$49.67B
/
$4.69
Implied change from Q2 26 (Revenue/ EPS)
-0.31%
/
-37.05%
Implied change from Q3 25 (Revenue/ EPS)
-0.83%
/
-22.22%

Elevance Health, Inc. earnings per share and revenue

On Jul 15, 2026, ELV reported earnings of 7.45 USD per share (EPS) for Q2 26, beating the estimate of 6.26 USD, resulting in a 18.85% surprise. Revenue reached 49.83 billion, compared to an expected 49.19 billion, with a 1.30% difference. The market reacted with a -8.54% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 19 analysts forecast an EPS of 4.69 USD, with revenue projected to reach 49.67 billion USD, implying an decrease of -37.05% EPS, and decrease of -0.31% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
HealthEquity, Inc
Report Date
Aug 27, 2026 For Q2 27
Estimate
$1.20
Actual
$1.24
Surprise
+2.92%
logo
MiniMed Group, Inc. Common Stock
Report Date
Sep 01, 2026 For Q1 27
Estimate
$0.09
Actual
$0.00
Surprise
-100.00%
FAQ
For Q2 2026, Elevance Health, Inc. reported EPS of $7.45, beating estimates by 18.85%, and revenue of $49.83B, 1.3% above expectations.
The stock price moved down -8.54%, changed from $426.79 before the earnings release to $390.33 the day after.
The next earning report is scheduled for Oct 19, 2026.
Based on 19 analysts, Elevance Health, Inc. is expected to report EPS of $4.69 and revenue of $49.67B for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement